You are here

  • Home
  • Archive
  • Volume 90, Issue 1
  • From malignant mutations to malignant domains: the continuing search for prognostic significance in the mutant genes causing hypertrophic cardiomyopathy

Article Text

Article menu
Download PDFPDF
Editorial
From malignant mutations to malignant domains: the continuing search for prognostic significance in the mutant genes causing hypertrophic cardiomyopathy
  1. S L Van Driest1,
  2. B J Maron2,
  3. M J Ackerman1,*
  1. 1Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
  2. 2The Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA
  1. Correspondence to:
    Michael J Ackerman
    MD, PhD, Sudden Death Genomics Laboratory, Mayo Clinic College of Medicine, 200 First Street SW, Guggenheim 501, Rochester, MN 55905, USA; ackerman.michaelmayo.edu

Abstract

The genetic causes of hypertrophic cardiomyopathy are diverse and thus present challenges in the development of genetic tests to identify patients at risk

  • hypertrophic cardiomyopathy
  • genetics
  • β myosin heavy chain gene

https://doi.org/10.1136/heart.90.1.7

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • ↵* Also Departments of Medicine and Pediatrics/Divisions of Cardiovascular Diseases and Pediatric Cardiology, Mayo Clinic College of Medicine